342 related articles for article (PubMed ID: 33777292)
21. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
22. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
So H; Yuen CS; Yip RM
Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
[TBL] [Abstract][Full Text] [Related]
24. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
25. Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.
Kaplan SR; Escudero JN; Mecha J; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart GC; LaCourse SM
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):98-107. PubMed ID: 34629414
[TBL] [Abstract][Full Text] [Related]
26. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
Pettit AC; Stout JE; Belknap R; Benson CA; Séraphin MN; Lauzardo M; Horne DJ; Garfein RS; Maruri F; Ho CS;
Clin Infect Dis; 2021 Oct; 73(7):e2278-e2284. PubMed ID: 32761083
[TBL] [Abstract][Full Text] [Related]
27. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting.
Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31416206
[TBL] [Abstract][Full Text] [Related]
28. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
29. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
30. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Quantiferon-TB Gold and TST tests in the diagnosis of latent tuberculosis infection among HIV infected patients in Hamadan, west of Iran.
Keramat F; Bagheri Delavar B; Zamani A; Poorolajal J; Lajevardi E; Saadatmand A
J Infect Dev Ctries; 2020 Apr; 14(4):360-365. PubMed ID: 32379712
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
Ayubi E; Doosti-Irani A; Sanjari Moghaddam A; Sani M; Nazarzadeh M; Mostafavi E
PLoS One; 2016; 11(9):e0161983. PubMed ID: 27622293
[TBL] [Abstract][Full Text] [Related]
33. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
34. Tuberculin skin test and interferon-γ release assays: Can they agree?
Santos JA; Duarte R; Nunes C
Clin Respir J; 2023 Feb; 17(2):109-114. PubMed ID: 36526296
[TBL] [Abstract][Full Text] [Related]
35. Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test.
He Y; Cao X; Guo T; He Y; Du Y; Zhang H; Feng B; Du J; Zhang B; Wang K; Yan J; Wang D; Liu Z; Pan S; Xin H; Gao L
Front Public Health; 2022; 10():1025550. PubMed ID: 36530654
[TBL] [Abstract][Full Text] [Related]
36. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
[TBL] [Abstract][Full Text] [Related]
37. Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients.
Chalid MT; Puspawaty D; Tahir AM; Najdah H; Massi MN
Int J Mycobacteriol; 2022; 11(4):364-370. PubMed ID: 36510919
[TBL] [Abstract][Full Text] [Related]
38. The association of smoking with IGRA and TST results in HIV-1-infected subjects.
Aichelburg MC; Mandorfer M; Tittes J; Breitenecker F; Reiberger T; Rieger A; Kohrgruber N
Int J Tuberc Lung Dis; 2014 Jun; 18(6):709-16. PubMed ID: 24903943
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.
Wolf T; Goetsch U; Oremek G; Bickel M; Khaykin P; Haberl A; Bellinger O; Gottschalk R; Brodt HR; Stephan C
J Infect; 2013 Apr; 66(4):376-80. PubMed ID: 23159357
[TBL] [Abstract][Full Text] [Related]
40. Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia.
Reviono R; Saptawati L; Redhono D; Suryawati B
J Korean Med Sci; 2019 Oct; 34(40):e259. PubMed ID: 31625291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
